Summary:
A Master Protocol for Randomized, Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis
Qualified Participants Must:
• 18-70 years old
•
Diagnosed with moderate to severe atopic dermatitis (eczema)
• Applied at least 1 emollient every day for at least 2 weeks
Qualified Participants May Receive:
- Compensation for time and travel.
- Study-related care at no cost.